Top 5 Tech Companies To Watch In Right Now

Top 5 Tech Companies To Watch In Right Now: InterMune Inc.(ITMN)

InterMune, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of therapies in pulmonology and fibrotic diseases. In pulmonology, the company focuses on therapies for the treatment of idiopathic pulmonary fibrosis (IPF), a progressive and fatal lung disease. It markets pirfenidone, an orally active drug that inhibits the synthesis of TGF-beta under the Esbriet name in the European Union, as well as in a Phase III clinical trial in the United States. Pirfenidone is also approved for the treatment of IPF in Japan, where it is marketed by Shionogi & Co. Ltd. under the Pirespa trade name. The company?s research programs focus on the discovery of small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. InterMune, Inc. was founded in 1998 and is headquartered in Brisbane, California.

Advisors' Opinion:

• [By Sean Williams]

  InterMune (NASDAQ: ITMN  )
  InterMune shares may have exploded higher by 30% over the past week, but there's certain to be a lot of nail-biting on the part of shareholders as we head into earnings season. The reason has been the slow acceptance of the company's idiopathic pulmonary fibrosis drug, Esbriet, based on its pricing in the EU. In previous quarters Esbriet sales have disappointed in a big way, but are expected to rise by 134% to nearly $13 million from last year, though losses are still anticipated to come in at $0.70 per share. Following its recent pop, Esbriet sales had better hit the mark, otherwise InterMune shareholders are probably going to be in for a long day.

• [By John Udovich]

  The biotech sector may have lost some favor on Wall Street, but there is still plenty of interesting or overlooked news about the sector and/or biotech stocks like InterMune Inc (NASDAQ: ITMN), Biogen Idec Inc (NASDAQ: BIIB), Alexion Pharmaceuticals, Inc (NASDAQ: ! ALXN), United Therapeutics Corporation (NASDAQ: UTHR) and TNI BioTech, Inc (OTCMKTS: TNIB):

• [By Rich Smith]

  On Thursday, the Securities and Exchange Commission charged a former vice president of finance, accounting officer, and controller of InterMune (NASDAQ: ITMN  ) with insider trading.

• [By Ben Levisohn]

  InterMune (ITMN) has ticked up 0.2% despite being downgraded by JPMorgan and JMP Securities.

  DSW (DSW) had jumped 12% to $31.90 after the shoe retailer beat earnings forecasts and raised its guidance.

source from Top Stocks To Buy For 2015:http://www.topstocksforum.com/top-5-tech-companies-to-watch-in-right-now-2.html